Molecular Devices is planning to open new offices in China and India and intends to expand its South American operations this year, CEO Joe Keegan told BioCommerce Week.

Keegan also said the company will continue to follow its past strategy of making one small acquisition per year, and cautioned that as Molecular Devices itself matures into an attractive acquisition target, the company would not come cheap.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.